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Abstract Ellis–van Creveld (EvC) syndrome is a congenital
malformation syndrome with marked growth retardation. In
this study, specific growth charts for EvC patients were
derived to allow better follow-up of growth and earlier
detection of growth patterns unusual for EvC. With the use
of 235 observations of 101 EvC patients (49 males, 52
females), growth charts for males and females from 0 to
20yearsofagewerederived.Longitudinalandcross-sectional
data were collected from an earlier review of growth data in
EvC,adatabaseofEvCpatients,andfromrecentliterature.To
model the growth charts, the GAMLSS package for the R
statistical program was used. Height of EvC patients was
comparedtohealthychildrenusingDutchgrowthcharts.Data
are presented both on a scale for age and on a scale for the
squarerootofage.ComparedtohealthyDutchchildren,mean
height standard deviation score values for male and female
EvC patients were −3.1 and −3.0, respectively. The present
growth charts should be useful in the follow-up of EvC
patients. Most importantly, early detection of growth hor-
mone deficiency, known to occur in EvC, will be facilitated.
Keywords Growth.Body height.Ellis–van Creveld
syndrome.Growth charts
Introduction
Ellis–van Creveld syndrome (EvC) (OMIM # 225500) is a
skeletal dysplasia characterized by short limbs, short ribs,
postaxial polydactyly, and dysplastic nails and teeth. Sixty
percent of affected individuals have a congenital cardiac
defect, most commonly an atrial septum defect [3, 4]. The
syndrome is named after the physicians Ellis and van
Creveld, who described the first cases in 1940 [4]. EvC is
uncommon, the incidence in the general population being 7
per 1,000,000 live births [15]. In the Old Amish population,
the incidence is much higher, with 5 per 1,000 live births
and as many as 13% of the Amish people are carrier of the
mutation [8]. The disorder follows an autosomal recessive
pattern of inheritance. Mutations in two genes (EVC and
EVC2) on chromosome 4p16 have been identified to be
responsible for the EVC phenotype [12].
After birth, children with EVC present with short limbs.
The shortening of the limbs increases from proximal to
distal, with the most pronounced shortening of the distal
interphalangeal bones. A recent study showed that growth
hormone deficiency can play a role in the retarded growth
in at least some EvC patients [19]. The same study showed
variation of the growth retardation from −2.0 to −4.5
standard deviation score (SDS) of average height. The
S. Verbeek (*): F. G. A. Versteegh
Department of Pediatrics, Groene Hart Ziekenhuis,
P.O. Box 1098, Gouda, The Netherlands
e-mail: sabineverbeek@hotmail.com
F. G. A. Versteegh
e-mail: florens.versteegh@ghz.nl
P. H. C. Eilers
Department of Medical Statistics, Erasmus Medical Centre,
Rotterdam, The Netherlands
K. Lawrence
Springburn Health Centre,
Glasgow, Scotland, UK
R. C. M. Hennekam
Institute for Child Health,
Great Ormond Street Hospital for Children, UCL,
London, UK
R. C. M. Hennekam
Department of Pediatrics, Academic Medical Center,
Amsterdam, The Netherlands
Eur J Pediatr (2011) 170:207–211
DOI 10.1007/s00431-010-1287-3authors argued that growth charts specifically for EvC
patients would be useful, as has been found for other
entities that go along marked growth retardation, such as
Down syndrome, Turner syndrome, and achondroplasia [5,
10, 16, 18]. Such dedicated growth charts allow better
follow-up of growth and earlier detection of growth
patterns unusual for the entity involved. This urged us to
create growth charts specifically for children with EvC.
Methods
Patients
Growth data of 101 EvC patients were available for
analysis. Data were gathered from different sources. For
our previous study [19], we gathered measurements of 80
patients. From these studies, four patients were known to
receive therapy for growth hormone deficiency and were
therefore excluded. All cases from literature that were
molecularly proven were added; patients of whom molec-
ular results were not available were included if the
diagnosis was thought to be right by an experienced
clinical geneticist. One hundred and three measurements
of 76 patients from these studies were used for analysis.
Secondly, we used the database of an EvC website
(www.ellisvancreveld.co.uk). This database provided 126
data points of 19 subjects with EvC. In all latter patients,
the diagnosis was molecularly proven. There was no
overlap between subjects of this database and subjects
from our previous studies. Thirdly, we added data from
literature published after our 2007 study was concluded
[1, 3, 17]. This provided us eight measurements of six
patients. In total, 229 usable data were available of 101
patients—106 data points of 49 males and 123 data points
of 52 females.
Statistical analysis
To model the growth charts, the GAMLSS package for the
R statistical program (R Development Core Team, 2009)
was used [13]. GAMLSS models the conditional distribu-
tion of height for a given age by means of three curves: one
for the mean, one for the (logarithm of the) standard
deviation, and one for a power transformation to normality.
To find the best balance between complexity and fit to
the data, transformation to normality was not performed,
and linear trends (in the square root of age) were taken for
the mean curve and the logarithm of the standard deviation.
With this model, percentile curves were computed.
To compare height of EvC patients with height in
healthy children, we presented the data in digital Dutch
growth curves [7].
Results
A total of 229 measurements on 101 subjects were used for
the analysis. Of 29 subjects, we gathered more than 1, and
of 12 subjects, we gathered more than 5 measurements
(Table 1). Of the 52 female subjects, 48 were aged between
0 and 20 years and 4 subjects were above 20 years. We
assumed height of these patients would be comparable with
20-year-old patients and therefore treated these data points
as such. Indeed, if leaving these data points outside the
analysis, the growth curves did not change. Of the 49 male
subjects, 42 were aged between 0 and 18 years and 6 were
above 20 years of age. Again, we treated the data of these
patients as if they were 20-year-old patients. As in the
females, the growth curve did not change if these data
points were left out of the analysis.
Data from the literature were published between 1940
and 2009. Ethnicity differed since data were gathered from
all over the world. Most of the patients (n=60) were of
Caucasian descent, 15 were Hispanic, 24 patients had other
ethnic backgrounds (African-American, Jewish, Turkish,
Chinese, Mongolian, Japanese, Indian), and of 2 patients
from literature, the ethnicity was not known. Consanguinity
of parents in patients collected from the literature was
mostly unknown to us. In the UK database, none of the
parents was consanguineous.
The growth charts were derived for males from 0 to
20 years of age (Figs. 1, 2, and 5) and females from 0 to 20
(Figs. 3, 4, and 6). Transformation of age to a different
scale, by taking square roots, led to almost linear curves
(Figs. 1 and 3). Figures 2 and 4 show growth charts for
boys and girls, respectively, with all the collected data
points. Figures 5 and 6 show the same growth charts
without these data points, to allow use for patient care
purposes. Curves are made for the specific age group. The
statistical program used here does not make it possible to
extrapolate data points to adulthood.
Height SDS values for EvC patients are shown on Dutch
growth charts for boys (Fig. 7) and girls (Fig. 8)o f0 –
Table 1 Patient characteristics
Age group (years) Male data points
(n)/ male patients
in age group (n)
Female data points
(n)/ female patients
in age group (n)
0–1 36/18 63/28
1–5 38/15 34/15
5–12 16/13 13/8
12–20 10/10 9/8
>20 6/6 4/4
Total 106/62 123/63
Data points of male and female patients per age group
208 Eur J Pediatr (2011) 170:207–21121 years. SDS values vary between +1.4 and −8.6, with a
mean of −3.1 SD for male EvC patients and −3.0 SD for
female EvC patients [7].
Discussion
Syndrome-specific growth charts have been developed for
several syndromes, such as Down syndrome, Turner
syndrome, and Williams syndrome [5, 10, 16]. These charts
have proven to be a helpful tool in the medical care of these
children. Growth in EvC is known to be impaired, with an
estimated deviation of −2.0 to −4.5 from standard growth
[19]. Until recently, it was assumed to be explainable
merely because of the skeletal dysplasia. However, growth
hormone deficiency has been reported in patients with EvC
and its frequency remains uncertain [19]. This may
aggravate the growth retardation. To detect growth hor-
mone deficiency and other disorders that cause additional
growth deviation in EvC patients, specific growth charts for
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Fig. 1 Growth chart for boys from 0 to 20 years of age with Ellis–van
Creveld syndrome (n=49). Curves presented as height (centimeters)
versus square root of age (years)
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Fig. 2 Growth chart for boys from 0 to 20 years of age with Ellis–van
Creveld syndrome (n=49). Curves presented as height (centimeters)
versus age (years)
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Fig. 3 Growth chart for girls from 0 to 20 years of age with Ellis–van
Creveld syndrome (n=52). Curves presented as height (centimeters)
versus square root of age (years)
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Fig. 4 Growth chart for girls from 0 to 20 years of age with Ellis–van
Creveld syndrome (n=52). Curves presented as height (centimeters)
versus age (years)
Eur J Pediatr (2011) 170:207–211 209children with EvC should be of great value. We present
here growth charts for males and females with EvC.
Since the data set was small, a simple model was aimed
for. Transformation of age to a different scale, by taking
square roots, led to almost linear curves. Furthermore, it
spreads out the data for the younger age group, which
makes it more clarifying.
We treated the data as cross-sectional although a number
of measurements come from the same individuals. There is
no provision in the statistical program GAMLSS for
grouped data. The alternative would be to select one
measurement per individual or leave repeated measure-
ments out completely. Both choices were unattractive.
Because our analysis is mainly descriptive, we believe that
little harm was done by using all data.
To compare growth of EvC patients to healthy children,
data were shown in Dutch growth charts. Mean growth
deviation was −3.1 SD for male patients and −3.0 SD for
female patients, comparable to our previous study [19].
A drawback of the present study is the possible influence
of the secular trend in growth. Data were gathered from
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Fig. 5 Growth chart for boys from 0 to 20 years of age with Ellis–van
Creveld syndrome
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Fig. 6 Growth chart for girls from 0 to 20 years of age with Ellis–van
Creveld syndrome
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Fig. 7 Dutch growth charts for boys (0–21 years, blue line) with
height SDS of boys with Ellis–van Creveld syndrome (0–20 years,
dotted line)
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Fig. 8 Dutch growth charts for girls (0–21 years, blue line) with
height SDS of girls with Ellis–van Creveld syndrome (0–20 years,
dotted line)
210 Eur J Pediatr (2011) 170:207–211publications between 1940 and 2009. Nowadays, boys and
girls are taller than in the 1940s [10, 14]. Although the
proportion of data from more than 30 years ago is relatively
small (28 data points), the influence of the secular trend
cannot be ruled out. Another drawback is that data were
gathered from all over the world. Consequently, the here
presented growth charts represent different cultures and
ethnicities, which can differ greatly [2, 9, 11]. We reasoned,
however, that in EvC the growth retardation would be that
extreme that this would easily outweigh the ethnic growth
differences and we therefore used all data.
When compared to regular growth charts, the here presented
growth charts differ in form. It seems that growth does not slow
down to a complete horizontal curve after puberty. The reason
for this is the statistical approach used in this study. Since the
data set was small, the formation of a splined curve was not
possible. Regular growth charts show an S-shaped or “splined”
curve. These curves flatten in adolescence, leading to an end
height or target height. The here presented growth charts are
developed with the use of another statistical approach, used for
smaller databases [13]. This method does not allow extrapo-
lation of the curve. Hence, the here presented growth charts
can only be used in a specific age group. More research with a
larger database would be necessary to develop growth charts
with a splined curve.
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